Calidi Biotherapeutics Statistics
NYSE: CLDIHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
1.03-0.01 (-0.96%)
Market open · Delayed 15 min · as of Oct 9, 11:09 AM ET
Calidi Biotherapeutics by the numbers
Calidi Biotherapeutics has a market capitalization of $3.8 million based on 3.68M shares outstanding. With trailing EPS of $-36.47, Calidi Biotherapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 22.4% below its 50-day average and 82.5% below its 200-day average.
Average daily trading volume is 255.53K shares, or about $263,195 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CLDI valuation vs. peer median
| Metric | CLDI | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.79M | $3.15M | +20% |
| Avg. volume | 255.53K | 870.80K | -71% |
Peer median across 8 companies: PMCB, SLXN, VIVS, LIMN, HLSQ, CRIS, SCNI, CELZ.
Valuation
- Market cap
- $3.79M
- EPS (TTM)
- $-36.47
- Shares outstanding
- 3.68M
Price and trading
- Previous close
- 1.04
- Open
- 1.04
- Day range
- 1.03 – 1.04
- 52-week range
- 0.986 – 27.84
- Beta
- —
- Volume
- 7.27K
- Average volume
- 255.53K
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 3.79M
- Forward Pe
- -1.14
- Eps
- -36.47
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 27.84
- Week52 Low
- 0.99
- Avg Volume
- 255.53K
- Shares Outstanding
- 3.68M
- Ma50
- 1.33
- Ma200
- 5.90
- Pct From52w High
- -96.30%
- Pct From52w Low
- 4.46%